Transforming cancer's faintest traces into medicine's most powerful tools
Freenome is changing the way the world looks at cancer by decoding the vast complexity of the cell-free genome – where breakthroughs in artificial intelligence turn hidden patterns into tools for early detection of cancer, and novel pathways are revealing new and better ways to treat.
Blood tests for early cancer detection and enhanced drug development
Early Cancer Detection
Simple and accurate blood tests that can detect cancer in its earliest stages, before symptoms occur.
Solving unmet needs in precision oncology and immuno-oncology with accurate companion diagnostics and biomarker identification.
Collaborating with academic and pharmaceutical partners to identify new therapeutic targets.
Lifesaving early cancer detection
For the 8 most common cancers, starting eﬀective treatment during stage 1 or 2 has demonstrated 10-year survival rates of 80% to 90%.1 Unfortunately, current screening approaches often fail to detect cancer until signiﬁcant progression has already occurred.
Optimizing cancer treatment
In addition to early cancer detection, classifying the billions of patterns that deﬁne each tumor type can help oncologists predict which therapy is likely to work best. Over time, the data we collect is revealing new targets for the next generation of cancer therapies.